Sarepta FDA Shipment Halt - Search News

Order byBest matchMost fresh

News

Sarepta Will Resume Gene Therapy Shipments

· 1d · on MSN

Sarepta resumes shipping of gene therapy Elevidys to patients who can walk

Sarepta Therapeutics said on Monday it will resume shipping of its muscular disorder gene therapy to patients who can walk, sending the company's shares 59% higher in extended trading.

Continue reading

· 12h · on MSN

Sarepta Soars After FDA Says Some Patients Can Get Elevidys

· 1d · on MSN

Sarepta will resume gene therapy shipments after FDA review of recent patient death

8h

FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers

Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.

8d

Sarepta Therapeutics stock sinks further Tuesday after halting shipment of bestselling drug Elevidys

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results